Why is Ozempic so expensive in the US? A pricing breakdown

TLDR. In the US, GLP-1 drugs cost more than almost anywhere on earth. Ozempic lists near $969 a month and Wegovy near $1,349, per the Senate HELP Committee. In the United Kingdom the same molecule runs about $92, per Fortune. A 2024 JAMA Network Open analysis estimated semaglutide can be manufactured for between $0.89 and $4.73 a month. Three things explain the gap: a patent monopoly with no generic until about 2032, markups from pharmacy benefit managers and wholesalers that take close to $700 of the list price, and a legal ban that kept Medicare from negotiating drug prices for two decades. If you need to pay less this month, the cheapest legitimate routes are at the end of this piece.

The price gap (US vs other countries)

The US pays more for semaglutide than any other country. When Senator Bernie Sanders and the Senate HELP Committee opened their investigation into the price of Ozempic and Wegovy, they put Ozempic's US list price at about $969 a month and Wegovy's at about $1,349. The committee's own comparison found the same Ozempic pen selling for roughly $155 in Canada and $59 in Germany. Fortune reported the UK price at about $92. Healthline's review of international pricing reached the same conclusion. The US is the outlier, often by a factor of ten or more.

What it actually costs to make (the JAMA estimate)

None of those prices reflect what the drug costs to produce. A 2024 JAMA Network Open analysis modeled the cost of manufacturing semaglutide at scale, including the active ingredient, the fill-and-finish work, packaging and a profit margin. The estimate came to between $0.89 and $4.73 a month. Even at the high end, that is under 1 percent of the US list price. The distance between $5 and $969 is not production. It is everything layered on top.

Where the money goes (patent monopoly and PBM markups)

Two structures hold the price up. The first is the patent. Novo Nordisk holds the patents on semaglutide, and its core US protection runs to about 2032 per the company's filings. No generic can enter and undercut the price until then, so a single seller sets the number with no competitor to check it.

The second is the chain between the factory and the pharmacy counter. The list price is not what Novo Nordisk keeps. Pharmacy benefit managers, wholesalers and pharmacies each take a cut through rebates, fees and the spread between what they pay and what they charge. The Senate HELP Committee's analysis found these middlemen collecting close to $700 of the list price on GLP-1 fills. The rebates are negotiated in private, which is part of why the markup is hard to see from the outside.

Why Medicare cannot negotiate

For most of the program's history, Medicare, the largest drug buyer in the country, was legally forbidden from bargaining over price. The 2003 law that created Medicare's drug benefit included a non-interference clause, in force from 2006, that barred the government from negotiating directly with manufacturers. Private insurers could negotiate. Medicare could not. The 2022 Inflation Reduction Act changed this for a short list of drugs, and Medicare selected semaglutide (Ozempic, Wegovy and Rybelsus) for negotiation in 2025, with the negotiated prices set to take effect in 2027. Until then, and for everyone outside Medicare, the list price stands.

How to pay less than list today

You cannot rewrite patent law this month. You can pay far less than $969. Here is the order of operations, cheapest legitimate route first.

The lowest price is compounded semaglutide, which runs about $149 to $178 a month at the programs we track, including Strut Health and Mochi. See the cheapest GLP-1 programs for the current list. Brand routes cost more but ship direct from the manufacturer: oral Wegovy is $299 a month, and LillyDirect sells Zepbound for $299 to $449. Before you pay, check manufacturer savings and coupons, where the copay cards and direct-cash programs sit in one place. If you are on Medicare, the Medicare GLP-1 Bridge caps Wegovy, Foundayo (the oral GLP-1), and the Zepbound KwikPen at $50 a month from July 2026. To line every program up on price and terms, use our comparison chart.

Frequently asked questions

How much does Ozempic cost without insurance?

Ozempic's US list price is about $969 a month, per the Senate HELP Committee. Cash-pay patients rarely need to pay the full list. Compounded semaglutide runs about $149 to $178 a month, and manufacturer savings cards can cut the brand price further. See the cheapest GLP-1 programs for current cash prices.

Is Ozempic cheaper in Canada or Mexico?

Yes. The Senate HELP Committee put Ozempic's Canadian list price near $155 a month against about $969 in the US. Personal importation sits in a legal gray area and supply is not guaranteed, so most US patients reach a lower price through compounded semaglutide or a manufacturer-direct program instead. The wider point holds: the US pays more than every other country.

Why is the US price so much higher than the UK?

Three reasons stack up. Novo Nordisk holds a patent monopoly with no US generic until about 2032. Pharmacy benefit managers and wholesalers take close to $700 of the list price. And Medicare was barred from negotiating drug prices for two decades. The UK's National Health Service negotiates one price for the entire country, which is how it lands near $92 a month, per Fortune.